Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NAPROXEN 500MG TABLET Actual shortage 2024-05-16 2024-05-16 228140
TEVA-DOMPERIDONE 10MG TABLET Resolved 2024-02-29 2024-05-16 220980
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-16 215737
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
FENTORA 800MCG TABLET (EFFERVESCENT) Resolved 2024-05-09 2024-05-16 227506
TEVA-CARVEDILOL 3.125MG TABLET Actual shortage 2024-05-09 2024-05-16 227471
TEVA-CARVEDILOL 6.25MG TABLET Actual shortage 2024-05-09 2024-05-16 227474
TEVA-MOMETASONE 0.1% OINTMENT Actual shortage 2024-02-29 2024-05-16 220986
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Actual shortage 2024-05-03 2024-05-16 226939
TEVA-BUDESONIDE 0.5MG SUSPENSION Actual shortage 2023-06-19 2024-05-16 195478
TEVA-TECNAL 330MG 40MG 50MG CAPSULE Actual shortage 2024-04-05 2024-05-16 224448
TEVA-SUCRALFATE 1G TABLET Actual shortage 2023-12-14 2024-05-16 213368
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166975
TEVA-FLUOXETINE 20MG CAPSULE Resolved 2022-01-27 2024-05-10 153721
TEVA-FLUOXETINE 10MG CAPSULE Resolved 2022-01-27 2024-05-09 153718
TEVA-FLUOXETINE 20MG CAPSULE Resolved 2022-02-17 2024-05-09 155171
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-09 215740
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-18 2024-05-09 216466

Showing 41 to 60 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104283
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104263

Showing 81 to 100 of 250